UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regional brain shrinkage over two years: Individual differences and effects of pro-inflammatory genetic polymorphisms

NeuroImage (Orlando, Fla.), 2014-12, Vol.103, p.334-348

2014

Volltextzugriff (PDF)

Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing–remitting multiple sclerosis

European journal of neurology, 2017-05, Vol.24 (5), p.703-712

2017

Volltextzugriff (PDF)

Longitudinal anti‐nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent‐onset disease

Clinical and experimental immunology, 2020-03, Vol.199 (3), p.245-254

2020

Volltextzugriff (PDF)

Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid

Multiple sclerosis, 2010-02, Vol.16 (2), p.208-217

2010

Volltextzugriff (PDF)

Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab‐treated multiple sclerosis

European journal of neurology, 2017-01, Vol.24 (1), p.112-121

2017

Volltextzugriff (PDF)

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs

Multiple sclerosis, 2013-05, Vol.19 (6), p.765-774

2013

Volltextzugriff (PDF)

Antibodies against deamidated gliadin peptides identify adult coeliac disease patients negative for antibodies against endomysium and tissue transglutaminase

Alimentary pharmacology & therapeutics, 2010-07, Vol.32 (2), p.254-260

2010

Volltextzugriff (PDF)

Circulating cartilage oligomeric matrix protein in juvenile idiopathic arthritis

Scandinavian journal of rheumatology, 2017-05, Vol.46 (3), p.194-197

2017

Volltextzugriff (PDF)

IgA antibodies against tissue transglutaminase, endomysium and gliadin in idiopathic polyneuropathy

Acta neurologica Scandinavica, 2013-02, Vol.127 (2), p.109-115

2013

Volltextzugriff (PDF)

Transcriptional characteristics of CD4+ T cells in multiple sclerosis: Relative lack of suppressive populations in blood

Multiple sclerosis, 2011-01, Vol.17 (1), p.57-66

2011

Volltextzugriff (PDF)

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

Annals of neurology, 2011-01, Vol.69 (1), p.83-89

2011

Volltextzugriff (PDF)

Regional Brain Changes in Aging Healthy Adults: General Trends, Individual Differences and Modifiers

Cerebral cortex (New York, N.Y. 1991), 2005-11, Vol.15 (11), p.1676-1689

2005

Volltextzugriff (PDF)

Interleukin-8 is elevated in cerebrospinal fluid following high-voltage electrical injury with late-onset paraplegia suggesting neuronal damage at the microlevel as causative factor

Burns, 2010-05, Vol.36 (3), p.e7-e9

2010

Volltextzugriff (PDF)

Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor

Blood, 1998-11, Vol.92 (10), p.3730-3736

1998

Volltextzugriff (PDF)

Prominent epigenetic and transcriptomic changes in CD4 + and CD8 + T cells during and after pregnancy in women with multiple sclerosis and controls

Journal of neuroinflammation, 2023-04, Vol.20 (1), p.98-98, Article 98

2023

Volltextzugriff (PDF)

IgA rheumatoid factor in rheumatoid arthritis

Clinical chemistry and laboratory medicine, 2022-09, Vol.60 (10), p.1617-1626

2022

Volltextzugriff (PDF)

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis

Multiple sclerosis, 2011-06, Vol.17 (6), p.708-719

2011

Volltextzugriff (PDF)

Selective IgA deficiency in autoimmune diseases

Molecular medicine (Cambridge, Mass.), 2011, Vol.17 (11-12), p.1383-1396

2011

Volltextzugriff (PDF)

Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results

Rheumatic & musculoskeletal diseases open, 2022-03, Vol.8 (1), p.e002099

2022

Volltextzugriff (PDF)

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

European journal of neurology, 2011-01, Vol.18 (1), p.69-77

2011

Volltextzugriff (PDF)

Serological assessment for celiac disease in IgA deficient adults

PloS one, 2014, Vol.9 (4), p.e93180-e93180

2014

Volltextzugriff (PDF)

Regional brain shrinkage and change in cognitive performance over two years: The bidirectional influences of the brain and cognitive reserve factors

NeuroImage (Orlando, Fla.), 2016-02, Vol.126, p.15-26

2016

Volltextzugriff (PDF)

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS

Neurology, 2011-10, Vol.77 (16), p.1551-1560

2011

Volltextzugriff (PDF)

Elevated number of cells secreting transforming growth factor β in Guillain-Barré syndrome

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2003-12, Vol.111 (12), p.1095-1104

2003

Volltextzugriff (PDF)

Isolating RNA from whole blood - the dawn of RNA-based diagnosis?

Nature (London), 1993-03, Vol.362 (6416), p.186-188

1993

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(86)
Tagungsberichte
(1)

Sprache

Englisch
(86)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regional brain shrinkage over two years: Individual differences and effects of pro-inflammatory genetic polymorphisms

Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing–remitting multiple sclerosis

Longitudinal anti‐nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent‐onset disease

Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid

Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab‐treated multiple sclerosis

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs

Antibodies against deamidated gliadin peptides identify adult coeliac disease patients negative for antibodies against endomysium and tissue transglutaminase

Circulating cartilage oligomeric matrix protein in juvenile idiopathic arthritis

IgA antibodies against tissue transglutaminase, endomysium and gliadin in idiopathic polyneuropathy

Transcriptional characteristics of CD4+ T cells in multiple sclerosis: Relative lack of suppressive populations in blood

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

Regional Brain Changes in Aging Healthy Adults: General Trends, Individual Differences and Modifiers

Interleukin-8 is elevated in cerebrospinal fluid following high-voltage electrical injury with late-onset paraplegia suggesting neuronal damage at the microlevel as causative factor

Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor

Prominent epigenetic and transcriptomic changes in CD4 + and CD8 + T cells during and after pregnancy in women with multiple sclerosis and controls

IgA rheumatoid factor in rheumatoid arthritis

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis

Selective IgA deficiency in autoimmune diseases

Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

Serological assessment for celiac disease in IgA deficient adults

Regional brain shrinkage and change in cognitive performance over two years: The bidirectional influences of the brain and cognitive reserve factors

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS

Elevated number of cells secreting transforming growth factor β in Guillain-Barré syndrome

Isolating RNA from whole blood - the dawn of RNA-based diagnosis?

Aktive Filter

Suchergebnisse filtern